STADA Arzneimittel AG 

29.01.2013 13:38

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Notification of voting rights pursuant to sec. 25a WpHG
We received the following notification pursuant to sec. 25a WpHG on January
24, 2013:

1. Listed company:
STADA Arzneimittel AG
Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

2. Notifier:
Societe Generale SA, Paris, Frankreich 

3. Triggering event:
Exceeding Threshold

4. Threshold(s) crossed or reached:
10%

5. Date at which the threshold is crossed or reached:
18.01.2013

6. Total amount of voting rights:
11.35% (equals 6734193 voting rights)
calculated from the following total number of voting rights issued:
59332260

7. Detailed information on the voting rights proportion:

Voting rights proportion based on financial/other instruments pursuant to
sec. 25a WpHG:
11.10% (equals 6587607 voting rights)

thereof held indirectly:
5.56% (equals 3297000 voting rights)

Voting rights proportion based on financial/other instruments pursuant to
sec. 25 WpHG:
0.18% (equals 105220 voting rights)

thereof held indirectly:
0% (equals 0 voting rights)

Voting rights pursuant to sec. 21, 22 WpHG:
0.07% (equals 41366 voting rights)

8. Detailed information on financial/other instruments pursuant to sec. 25a
WpHG:

Chain of controlled undertakings:
Societe Generale Effekten GmbH

ISIN or name/description of the financial/other instrument: DE000SG0ELV6
Maturity: 03.01.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG147K1
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG147L9
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG26068
Maturity: 19.12.2014
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG26076
Maturity: 19.12.2014
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG26084
Maturity: 19.12.2014
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG2HQT8
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN34
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: DE0000SG3UN42
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN59
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN67
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN75
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN83
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UN91
Maturity: 15.12.2017
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UPA1
Maturity: 15.12.2017
Expiration date: 

ISIN or name/description of the financial/other instrument: DE000SG3UPB9
Maturity: 15.12.2017
Expiration date: 

ISIN or name/description of the financial/other instrument: structured call
option
Maturity: 19.12.2014
Expiration date: 

ISIN or name/description of the financial/other instrument: structured call
option
Maturity: 18.12.2015
Expiration date: 

ISIN or name/description of the financial/other instrument: structured call
option
Maturity: 16.12.2016
Expiration date: 

ISIN or name/description of the financial/other instrument: structured call
option
Maturity: 15.12.2017
Expiration date: 

ISIN or name/description of the financial/other instrument: structured call
option
Maturity: 03.01.2025
Expiration date: 

ISIN or name/description of the financial/other instrument: DE0007251845
Maturity: 26.06.2015
Expiration date: 



29.01.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Internet:     www.stada.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------